Ignite Creation Date:
2024-05-06 @ 6:57 PM
Last Modification Date:
2024-10-26 @ 2:57 PM
Study NCT ID:
NCT05841342
Status:
RECRUITING
Last Update Posted:
2023-05-03
First Post:
2023-04-22
Brief Title:
Prospective Study of Immune Function and PD-1 Antibody Therapy Efficacy Predictors on CAEBV and EBV-HLH Patients
Sponsor:
Organization:
Beijing Friendship Hospital
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
10ml venous blood was extracted and peripheral blood mononuclear cells were extracted for flow cytometry detection The detection contents included the frequencies of lymphocyte subsets the positive proportion of PD-1PD-L1 and EBER positive proportion in each subgroup
Enrollment Count:
128
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Case-Control |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 95101 |
Who Masked List: